How many days of insulin supply will two Tandem Mobi (200 U) cartridges provide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Day Supply for Two Tandem Mobi Cartridges

Two Tandem Mobi cartridges (200 units each, total 400 units) will provide approximately 2-8 days of insulin supply for most patients, depending on their total daily insulin dose (TDI).

Calculating Day Supply

The day supply calculation is straightforward:

  • Total insulin available: 2 cartridges × 200 units = 400 units
  • Day supply formula: 400 units ÷ patient's TDI = number of days

Practical Examples by TDI:

Total Daily Insulin Day Supply from 400 Units
50 units/day 8 days
75 units/day 5.3 days
100 units/day 4 days
125 units/day 3.2 days
150 units/day 2.7 days
200 units/day 2 days

Determining Patient's TDI

To calculate the appropriate day supply, you must first establish the patient's TDI:

For insulin-naive patients 1, 2:

  • Start with 0.1-0.2 units/kg/day for elderly patients (≥70 years) or those with renal impairment
  • Use 0.3-0.5 units/kg/day for most other patients
  • Consider 0.4 units/kg/day for blood glucose 140-200 mg/dL
  • Consider 0.5 units/kg/day for blood glucose 201-400 mg/dL

For patients already on insulin:

  • Use their current documented TDI
  • Account for both basal (typically 50% of TDI) and bolus insulin (typically 50% of TDI) 1, 3

Special Considerations

High Insulin Requirements

For patients requiring >200 units/day 1:

  • Two 200-unit cartridges provide only 2 days of supply
  • Consider U-200 concentrated insulin off-label in pump systems to extend cartridge life 4, 5
  • U-200 provides the same dose in half the volume, effectively doubling cartridge capacity
  • Recent data shows U-200 use in automated insulin delivery systems increases time between cartridge changes from 2.2 to 3.0 days 5

Typical Adult Dosing Ranges

Based on clinical trial data 6:

  • Type 1 diabetes: Mean basal dose 0.36-0.49 units/kg/day, bolus 0.38-0.52 units/kg/day
  • Type 2 diabetes: Mean total dose can reach 0.52-0.77 units/kg/day

Documentation Requirements

For insurance and dispensing purposes, document:

  • Patient's current TDI (units/day)
  • Calculated day supply: 400 units ÷ TDI
  • Round down to nearest whole day for conservative estimate
  • For a 70 kg patient on 0.5 units/kg/day: TDI = 35 units, day supply = 11 days
  • For a 100 kg patient on 1.0 units/kg/day: TDI = 100 units, day supply = 4 days

Common Pitfalls

Avoid these errors:

  • Don't assume a standard day supply—it varies dramatically by patient
  • Don't forget to account for both basal and bolus insulin in TDI calculation
  • Don't overlook that pump cartridges should be changed every 2-3 days regardless of remaining insulin to prevent infusion set complications 7
  • For patients requiring frequent cartridge changes due to high TDI, consider discussing U-200 concentrated insulin as an option to reduce change frequency 4, 5

References

Related Questions

For a patient using U200 insulin in an insulin pump with a basal rate of 0.4 units per hour, an insulin‑to‑carbohydrate ratio (ICR) of 8 g per unit, and an insulin sensitivity factor (ISF) of 35 mg/dL per unit, what are the equivalent settings when switching to U100 insulin?
For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
What is the clinical significance of a +1 glucose result on a urine dipstick and how should it be evaluated?
Can performing 100 repetitions of moderate-to-heavy resistance exercises on large muscle groups every other day for 15 minutes improve insulin sensitivity and help manage pre-diabetes?
How can I switch a clonidine transdermal patch to an oral clonidine regimen, matching the dose?
Is apixaban (Eliquis) appropriate for a patient with atrial fibrillation who has a history of esophageal varices without prior bleeding?
In an adult patient with osteoporosis undergoing spinal surgery, should teriparatide (Forteo) be continued during and after the operation?
What is the recommended prophylaxis and treatment for travelers' diarrhea in a typical adult traveler without chronic illness?
What are the possible causes of tinnitus in a 40-year-old adult?
Can Pluvicto (lutetium‑177 vipivotide tetraxetan) cause anemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.